Comparative gene expression analysis of NKT cell subpopulations

Journal of Leukocyte Biology

Volumn 80, Issue 1, 2006, Pages 164-173

  Lin, Henry ^a   Nieda, Mie ^b   Hutton, Jonathon F ^c   Rozenkov, Vladislav ^a   Nicol, Andrew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c CHRI   (Australia)

Author keywords

galactosylceramide; Human; Microarray

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CYTOKINE RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOREGULATION; MICROARRAY ANALYSIS; NATURAL KILLER T CELL; PRIORITY JOURNAL;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; KILLER CELLS, NATURAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; SENSITIVITY AND SPECIFICITY;

EID: 33751521642     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0705421     Document Type: Article

References (73)

1. Yang, O. O., Racke, F. K., Nguyen, P. T., Gausling, R., Severino, M. E., Horton, H. F., Byrne, M. C., Strominger, J. L., Wilson, S. B. (2000) CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of Vα24JαQ T cells: a feedback mechanism for immune regulation. J. Immunol. 165, 3756-3762.
2. Exley, M., Garcia, J., Balk, S. P., Porcelli, S. (1997) Requirements for CD1d recognition by human invariant Vα24+ CD4-CD8- T cells. J. Exp. Med. 186, 109-120.
3. Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K., Juji, T. (1999) Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum. Immunol. 60, 10-19.
4. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., Brutkiewicz, R. R. (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268, 863-865.
5. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., Kronenberg, M. (1998) CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528.
6. Spada, F. M., Koezuka, Y., Porcelli, S. A. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529-1534.
7. Kikuchi, A., Nieda, M., Schmidt, C., Koezuka, Y., Ishihara, S., Ishikawa, Y., Tadokoro, K., Durrant, S., Boyd, A., Juji, T., Nicol, A.. (2001) In vitro anti-tumor activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma. Br. J. Cancer 85, 741-746.
8. Tahir, S. M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., Exley, M. A. (2001) Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167, 4046-4050.
9. Dhodapkar, M. V., Geller, M. D., Chang, D. H., Shimizu, K., Fujii, S., Dhodapkar, K. M., Krasovsky, J. (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 197, 1667-1676.
10. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., Strominger, J. L., Hafler, D. A.(1998) Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391, 177-181.
11. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Delovitch, T. L. (2002) Regulation of autoimmune disease by natural killer T cells. J. Mol. Med. 80, 290-300.
12. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E., Brenner, M. B. (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237.
13. Chen, Y. G., Choisy-Rossi, C. M., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J., Roopenian, D., Wilson, S. B., Serreze, D. V. (2005) Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 174, 1196-1204.
14. Duarte, N., Stenstrom, M., Campino, S., Bergman, M. L., Lundholm, M., Holmberg, D., Cardell, S. L. (2004) Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. J. Immunol. 173, 3112-3118.
15. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y., Taniguchi, M. (1998) Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95, 5690-5693.
16. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., Fujisawa, T., Shinkai, H., Taniguchi, M. (1999) Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells. Cancer Res. 59, 5102-5105.
17. Kim, H. Y., Kim, H. J., Min, H. S., Kim, S., Park, W. S., Park, S. H., Chung, D. H. (2005) NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J. Exp. Med. 201, 41-47.
18. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., Berzofsky, J. A. (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1, 515-520.
19. Moodycliffe, A. M., Nghiem, D., Clydesdale, G., Ullrich, S. E. (2000) Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1, 521-525.
20. Takahashi, T., Chiba, S., Nieda, M., Azuma, T., Ishihara, S., Shibata, Y., Juji, T., Hirai, H. (2002) Cutting edge: analysis of human V α24+CD8+ NK T cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 168, 3140-3144.
21. Takahashi, T., Nieda, M., Koezuka, Y., Nicol, A., Porcelli, S. A., Ishikawa, Y., Tadokoro, K., Hirai, H., Juji, T. (2000) Analysis of human V α 24+ CD4+ NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164, 4458-4464.
22. Gumperz, J. E., Miyake, S., Yamamura, T., Brenner, M. B. (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636.
23. Kim, C. H., Butcher, E. C., Johnston, B. (2002) Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23, 516-519.
24. Lee, P. T., Benlagha, K., Teyton, L., Bendelac, A. (2002) Distinct functional lineages of human V(α)24 natural killer T cells. J. Exp. Med. 195, 637-641.
25. van der Vliet, H. J., Nishi, N., Koezuka, Y., von Blomberg, B. M., van den Eertwegh, A. J., Porcelli, S. A., Pinedo, H. M., Scheper, R. J., Giaccone, G. (2001) Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods 247, 61-72.
26. Nishi, N., van der Vliet, H. J., Koezuka, Y., von Blomberg, B. M., Scheper, R. J., Pinedo, H. M., Giaccone, G. (2000) Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V α 24+V β 11+ T cells in vitro. Hum. Immunol. 61, 357-365.
27. Lin, H., Nieda, M., Nicol, A. J. (2004) Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. Eur. J. Immunol. 34, 2664-2671.
28. (2005) Database for Annotation, Visualization, and Integrated Discovery (DAVID). http://apps1.niaid.nih.gov/david/upload.asp.
29. Muller, P. Y., Janovjak, H., Miserez, A. R., Dobbie, Z. (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32, 1372-1374, 1376, 1378-1379.
30. Kim, C. H., Johnston, B., Butcher, E. C. (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24(+)Vβ11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100, 11-16.
31. Crough, T., Purdie, D. M., Okai, M., Maksoud, A., Nieda, M., Nicol, A. J. (2004) Modulation of human Vα24(+)Vβ11(+) NKT cells by age, malignancy and conventional anticancer therapies. Br. J. Cancer 91, 1880-1886.
32. Thomas, S. Y., Hou, R., Boyson, J. E., Means, T. K., Hess, C., Olson, D. P., Strominger, J. L., Brenner, M. B., Gumperz, J. E., Wilson, S. B., Luster, A. D. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580.
33. Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H. W., Loza, M. J., Perussia, B., Kronenberg, M., Seeger, R. C. (2001) Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167, 3114-3122.
34. Van Schoor, J., Joos, G. F., Pauwels, R. A. (2000) Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur. Respir. J. 16, 514-533.
35. Akbari, O., Stock, P., Meyer, E., Kronenberg, M., Sidobre, S., Nakayama, T., Taniguchi, M., Grusby, M. J., DeKruyff, R. H., Umetsu, D. T. (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9, 582-588.
36. Cerdan, C., Razanajaona, D., Martin, Y., Courcoul, M., Pavon, C., Mawas, C., Olive, D., Birg, F. (1992) Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) gene. J. Immunol. 149, 373-379.
37. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., Kaer, L. V., Kawano, T., Taniguchi, M., Nakui, M., Sekimoto, M., Koda, T. (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cell induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12, 987-994.
38. Hermans, I. F., Silk, J. D., Gileadi, U., Salio, M., Mathew, B., Ritter, G., Schmidt, R., Harris, A. L., Old, L., Cerundolo, V. (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171, 5140-5147.
39. Stober, D., Jomantaite, I., Schirmbeck, R., Reimann, J. (2003) NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo. J. Immunol. 170, 2540-2548.
40. Dunne, J., Lynch, S., O'Farrelly, C., Todryk, S., Hegarty, J. E., Feighery, C., Doherty, D. G. (2001) Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J. Immunol. 167, 3129-3138.
41. Lanier, L. L., Kipps, T. J., Phillips, J. H. (1985) Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J. Exp. Med. 162, 2089-2106.
42. Garcia, P., Llano, M., de Heredia, A. B., Willberg, C. B., Caparros, E., Aparicio, P., Braud, V. M., Lopez-Botet, M. (2002) Human T cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32, 936-944.
43. Bigouret, V., Hoffmann, T., Arlettaz, L., Villard, J., Colonna, M., Ticheli, A., Gratwohl, A., Samii, K., Chapuis, B., Rufer, N., Roosnek, E. (2003) Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 101, 3198-3204.
44. Biassoni, R., Cantoni, C., Marras, D., Giron-Michel, J., Falco, M., Moretta, L., Dimasi, N. (2003) Human natural killer cell receptors: insights into their molecular function and structure. J. Cell. Mol. Med. 7, 376-387.
45. Maeda, M., Shadeo, A., MacFadyen, A. M., Takei, F. (2004) CD1d-independent NKT cells in β 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172, 6115-6122.
46. Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., Imai, T. (2002) Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168, 6173-6180.
47. Taub, D. D., Proost, P., Murphy, W. J., Anver, M., Longo, D. L., van Damme, J., Oppenheim, J. J. (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95, 1370-1376.
48. Baggiolini, M., Dewald, B., Moser, B. (1997) Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705.
49. Wilson, S. B., Kent, S. C., Horton, H. F., Hill, A. A., Bollyky, P. L., Hafler, D. A., Strominger, J. L., Byrne, M. C. (2000) Multiple differences in gene expression in regulatory Vα 24Jα Q T cells from identical twins discordant for type I diabetes. Proc. Natl. Acad. Sci. USA 97, 7411-7416.
50. Kaplan, M. H., Sun, Y. L., Hoey, T., Grusby, M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
51. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A., Doherty, P. C., Grosveld, G. C., Ihle, J. N. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
52. Pericle, F., Pinto, L. A., Hicks, S., Kirken, R. A., Sconocchia, G., Rusnak, J., Dolan, M. J., Shearer, G. M., Segal, D. M. (1998) HIV-1 infection induces a selective reduction in STAT5 protein expression. J. Immunol. 160, 28-31.
53. Imada, K., Bloom, E. T., Nakajima, H., Horvath-Arcidiacono, J. A., Udy, G. B., Davey, H. W., Leonard, W. J. (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188, 2067-2074.
54. Pericle, F., Kirken, R. A., Bronte, V., Sconocchia, G., DaSilva, L., Segal, D. M. (1997) Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. J. Immunol. 159, 2580-2585.
55. Sandberg, J. K., Fast, N. M., Palacios, E. H., Fennelly, G., Dobroszycki, J., Palumbo, P., Wiznia, A., Grant, R. M., Bhardwaj, N., Rosenberg, M. G., Nixon, D. F. (2002) Selective loss of innate CD4(+) V α 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76, 7528-7534.
56. van der Vliet, H. J., von Blomberg, B. M., Hazenberg, M. D., Nishi, N., Otto, S. A., van Benthem, B. H., Prins, M., Claessen, F. A., van den Eertwegh, A. J., Giaccone, G., Miedema, F., Scheper, R. J., Pinedo, H. M. (2002) Selective decrease in circulating V α 24+V β 11+ NKT cells during HIV type 1 infection. J. Immunol. 168, 1490-1495.
57. Nicol, A., Nieda, M., Koezuka, Y., Porcelli, S., Suzuki, K., Tadokoro, K., Durrant, S., Juji, T. (2000) Human invariant Vα24+ natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumor activity through mechanisms distinct from T cells and natural killer cells. Immunology 99, 229-234.
58. Robinson, W. H., Landolfi, M. M., Parnes, J. R. (1997) Allele-specific expression of the mouse B-cell surface protein CD72 on T cells. Immunogenetics 45, 195-200.
59. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R., Thielemans, K. (1991) The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351, 662-665.
60. Luo, W., Van de Velde, H., von Hoegen, I., Parnes, J. R., Thielemans, K. (1992) Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148, 1630-1634.
61. Kitamura, H., Ohta, A., Sekimoto, M., Sato, M., Iwakabe, K., Nakui, M., Yahata, T., Meng, H., Koda, T., Nishimura, S., Kawano, T., Taniguchi, M., Nishimura, T. (2000) α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199, 37-42.
62. Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M., Askenase, P. W. (2003) Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198, 1785-1796.
63. Fujii, S., Liu, K., Smith, C., Bonito, A. J., Steinman, R. M. (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618.
64. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., Taniguchi, M., Nakui, M., Sekimoto, M., Koda, T. (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12, 987-994.
65. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P., Abrignani, S. (2003) CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051-1057.
66. Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R., Juji, T., Macfarlane, D. J., Nicol, A. J. (2004) Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383-389.
67. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., Moretta, L. (2000) Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today 21, 228-234.
68. Nicol, A., Nieda, M., Koezuka, Y., Porcelli, S., Suzuki, K., Tadokoro, K., Durrant, S., Juji, T. (2000) Dendritic cells are targets for human invariant Vα24+ natural killer T-cell cytotoxic activity: an important immune regulatory function. Exp. Hematol. 28, 276-282.
69. Hieshima, K., Imai, T., Opdenakker, G., Van Damme, J., Kusuda, J., Tei, H., Sakaki, Y., Takatsuki, K., Miura, R., Yoshie, O., Nomiyama, H. (1997) Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J. Biol. Chem. 272, 5846-5853.
70. Kenna, T., Golden-Mason, L., Porcelli, S. A., Koezuka, Y., Hegarty, J. E., O'Farrelly, C., Doherty, D. G. (2003) NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J. Immunol. 171, 1775-1779.
71. Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H., Baltimore, D. (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281, 1860-1863.
72. Yang, X., Khosravi-Far, R., Chang, H. Y., Baltimore, D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
73. Rogers, P. R., Matsumoto, A., Naidenko, O., Kronenberg, M., Mikayama, T., Kato, S. (2004) Expansion of human Vα24+ NKT cells by repeated stimulation with KRN7000. J. Immunol. Methods 285, 197-214.